all about the power of dendritic cells in changing the outcome of human diseases. Associate Professor of pathology and immunology @wustlmed #dendriticcell
Happy to share the early release of our work on CD5+ dendritic cells and their important role in anti-tumor immunity and response to Immunotherapy, now out at @ScienceMagazine. An incredible team work by Mingyu He, coauthor Kate Roussak and many others!! https://t.co/aVCrrujx6J
Looking forward to your talk @jonykipnis and to a great FOCIS 2026 meeting in San Francisco @FOCISimmunology Iโll also be speaking - sharing our work on tumor immune evasion. Join us for the great lineup and discussions
Looking forward to speaking at the FOCIS 2026 Annual Meeting, June 9โ12 in San Francisco. Iโll be presenting our new data on CNS Immune privilege (or lack thereof?) โdonโt miss it! | @FOCISimmunology | #focis
Thank you to the speakers and all the participants for the stimulating discussions and for making #LC2025 such a great success! Congratulations to all the award winners. Till next time #LC2027 in Sidney, Australia
Christophe Caux, who pioneered when Jacques Banchereau means to expand DCs from CD34 HPCs on IFN-III in the tumor micro environment amplifying IFng and CTL responses